QIM
KERX

Quantitative Investment Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Quantitative Investment Management’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-66,700
Closed -$473K – 936
2017
Q3 		$473K Buy
+66,700
New +$480K 0.01% 614
2017
Q2 		– Sell
-15,700
Closed -$96K – 968
2017
Q1 		$96K Sell
15,700
-213,900
-93% -$1.17M ﹤0.01% 663
2016
Q4 		$1.34M Buy
+229,600
New +$1.25M 0.03% 561
2016
Q2 		– Sell
-74,500
Closed -$347K – 1016
2016
Q1 		$347K Buy
+74,500
New +$297K 0.02% 603
2015
Q4 		– Sell
-67,500
Closed -$237K – 928
2015
Q3 		$237K Buy
+67,500
New +$452K 0.02% 581
2014
Q2 		– Sell
-78,800
Closed -$1.34M – 719
2014
Q1 		$1.34M Buy
+78,800
New +$1.19M 0.06% 198
2013
Q4 		– Sell
-18,200
Closed -$183K – 765
2013
Q3 		$183K Buy
18,200
+7,100
+64% +$63.2K 0.02% 509
2013
Q2 		$82K Buy
+11,100
New +$86.7K 0.01% 430

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quantitative Investment Management's KERX Position: Q4 2017 in Review

Quantitative Investment Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2017, closing a stake of 66,700 shares — an estimated $473K sold.

Quantitative Investment Management first reported a position in KERX in Q2 2013 and held it in 8 quarters. The position peaked at $1.34M in Q4 2016. 129 funds tracked by Wall St. Rank hold KERX as of Q4 2017.

  • Quantitative Investment Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Quantitative Investment Management sold 66,700 Keryx Biopharmaceuticals Inc shares in Q4 2017, an estimated $473K.
  • Quantitative Investment Management first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 8 quarters.
  • Quantitative Investment Management's Keryx Biopharmaceuticals Inc position peaked at $1.34M in Q4 2016.
  • 129 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2017.

Based on Quantitative Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.